Results 231 to 240 of about 89,725,173 (290)

Onasemnogene Abeparvovec in Patients With SMA: Interim Results of the RESTORE Registry in Japan

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective There are limited real‐world data regarding the safety and effectiveness of onasemnogene abeparvovec (OA; Zolgensma) infusion, a one‐time gene replacement therapy, for Japanese patients with spinal muscular atrophy (SMA). We aimed to improve understanding of the real‐world outcomes for OA in Japan.
Kayoko Saito   +8 more
wiley   +1 more source

DVIA technique for acute periprosthetic joint infection: a surgical technique and case series. [PDF]

open access: yesArthroplasty
Li M   +7 more
europepmc   +1 more source

Persistent critical illness in acute hypoxic respiratory failure: A retrospective cohort study. [PDF]

open access: yesPLoS One
Kalinoski M   +5 more
europepmc   +1 more source

Further Results Involving the Mean Time to Failure Order, and the Decreasing Mean Time to Failure Class

IEEE Transactions on Reliability, 2013
The purpose of this paper is to enhance the study of the mean time to failure (MTTF) order in an age replacement model, and the decreasing mean time to failure (DMTTF) class of life distributions. We present new characterizations of the MTTF order in terms of the well-known hazard rate and reversed hazard rate orders.
M. Kayid   +3 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy